Abstract |
The homeobox domain transcription factor PDX-1 is essential for pancreatic development and for the maintenance of beta-cell function. The participation of pancreatic duodenal homeobox factor-1 (PDX-1) in the transcription of several genes which are essential for glucose sensing and insulin synthesis underlines its key role in beta-cells of the pancreas. PDX-1 binds to the promoter of insulin, glucose transporter 2, and glucokinase and regulates their expression. By protein- protein interaction, PDX-1 acts in concert with other transcription factors or coactivators at the level of the insulin promoter. Ectopic expression of PDX-1 together with other cofactors can re-program cells to behave like beta-cells and produce insulin. This property of PDX-1 opens new strategies for the treatment of diabetes. Little is known about its regulation at the posttranslational level. Here, we report on its DNA-binding activity, the nuclear import and on post-translational modifications such as phosphorylation, glycosylation and sumoylation. Modulation of these post-translational modifications may be an alternate strategy for treating diabetes.
|
Authors | Faizeh Al-Quobaili, Mathias Montenarh |
Journal | International journal of molecular medicine
(Int J Mol Med)
Vol. 21
Issue 4
Pg. 399-404
(Apr 2008)
ISSN: 1107-3756 [Print] Greece |
PMID | 18360684
(Publication Type: Journal Article, Review)
|
Chemical References |
- Homeodomain Proteins
- Trans-Activators
- pancreatic and duodenal homeobox 1 protein
|
Topics |
- Binding Sites
- Diabetes Mellitus, Type 2
(etiology, genetics, metabolism)
- Homeodomain Proteins
(chemistry, genetics, metabolism)
- Humans
- Pancreas
(metabolism)
- Protein Processing, Post-Translational
- Protein Structure, Tertiary
- Trans-Activators
(chemistry, genetics, metabolism)
- Transcription, Genetic
|